Related references
Note: Only part of the references are listed.Reactive oxygen species (ROS)-responsive size-reducible nanoassemblies for deeper atherosclerotic plaque penetration and enhanced macrophage-targeted drug delivery
Jianhua He et al.
BIOACTIVE MATERIALS (2023)
Precision biomaterials in cancer theranostics and modelling
David Caballero et al.
BIOMATERIALS (2022)
Neoantigen-based personalized cancer vaccines: the emergence of precision cancer immunotherapy
Guilhem Richard et al.
EXPERT REVIEW OF VACCINES (2022)
Neoantigen Immunotherapeutic-Gel Combined with TIM-3 Blockade Effectively Restrains Orthotopic Hepatocellular Carcinoma Progression
Qingfu Zhao et al.
NANO LETTERS (2022)
Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs
Jian Zhao et al.
JOURNAL OF NANOBIOTECHNOLOGY (2022)
Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma
Mona O. Mohsen et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)
Two-Pronged Intracellular Co-Delivery of Antigen and Adjuvant for Synergistic Cancer Immunotherapy
Junli Meng et al.
ADVANCED MATERIALS (2022)
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation
Jessalyn J Baljon et al.
CURRENT OPINION IN IMMUNOLOGY (2022)
Neoantigen Identification and Response to Adoptive Cell Transfer in Anti-PD-1 Naive and Experienced Patients with Metastatic Melanoma
Shoshana T. Levi et al.
CLINICAL CANCER RESEARCH (2022)
Intranodal Administration of Neoantigen Peptide-loaded Dendritic Cell Vaccine Elicits Epitope-specific T Cell Responses and Clinical Effects in a Patient with Chemorefractory Ovarian Cancer with Malignant Ascites
Takashi Morisaki et al.
IMMUNOLOGICAL INVESTIGATIONS (2021)
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
Can Cui et al.
CELL (2021)
Nanobiomaterial-based vaccination immunotherapy of cancer
Fangmin Chen et al.
BIOMATERIALS (2021)
Personalized neoantigen vaccine prevents postoperative recurrence in hepatocellular carcinoma patients with vascular invasion
Zhixiong Cai et al.
MOLECULAR CANCER (2021)
TLR7 and RIG-I dual-adjuvant loaded nanoparticles drive broadened and synergistic responses in dendritic cells in vitro and generate unique cellular immune responses in influenza vaccination
Randall Toy et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Supramolecular co-assembly of self-adjuvanting nanofibrious peptide hydrogel enhances cancer vaccination by activating MyD88-dependent NF-κB signaling pathway without inflammation
Qi Su et al.
BIOACTIVE MATERIALS (2021)
Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology
Keman Cheng et al.
NATURE COMMUNICATIONS (2021)
Multifunctional biomolecule nanostructures for cancer therapy
Jing Wang et al.
NATURE REVIEWS MATERIALS (2021)
Nanovaccine-Mediated Cell Selective Delivery of Neoantigens Potentiating Adoptive Dendritic Cell Transfer for Personalized Immunization
Ping Xiao et al.
ADVANCED FUNCTIONAL MATERIALS (2021)
Rational Design of Immunomodulatory Hydrogels for Chronic Wound Healing
Mahshid Kharaziha et al.
ADVANCED MATERIALS (2021)
Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells
Kyung Soo Park et al.
BIOMATERIALS (2021)
Bacterial cytoplasmic membranes synergistically enhance the antitumor activity of autologous cancer vaccines
Long Chen et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
A modular self-adjuvanting cancer vaccine combined with an oncolytic vaccine induces potent antitumor immunity
Krishna Das et al.
NATURE COMMUNICATIONS (2021)
Targeting neoantigens for cancer immunotherapy
Xuan Zhao et al.
BIOMARKER RESEARCH (2021)
Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods
Emily K. Makowski et al.
MABS (2021)
Bacteria-Inspired Nanomedicine
Maya Holay et al.
ACS APPLIED BIO MATERIALS (2021)
Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development
Jie Liang et al.
CANCER BIOLOGY & MEDICINE (2021)
Non-small cell lung cancer tumour antigen, MUC-1 peptide-loaded non-aggregated poly (lactide-co-glycolide) nanoparticles augmented cellular uptake in mouse professional antigen-presenting cells: optimisation and characterisation
Kiran Jyoti et al.
JOURNAL OF MICROENCAPSULATION (2020)
Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models
Rui Zhang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2020)
Peptide Nanomaterials for Drug Delivery Applications
Sreekanth Pentlavalli et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2020)
Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines
Mariusz Skwarczynski et al.
SCIENCE ADVANCES (2020)
Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer
Samarth Hegde et al.
CANCER CELL (2020)
Redox-Responsive Polycondensate Neoepitope for Enhanced Personalized Cancer Vaccine
Lixia Wei et al.
ACS CENTRAL SCIENCE (2020)
Nanoparticles versus Dendritic Cells as Vehicles to Deliver mRNA Encoding Multiple Epitopes for Immunotherapy
Rebuma Firdessa-Fite et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
Qianqian Ni et al.
SCIENCE ADVANCES (2020)
Engineering Polymeric Prodrug Nanoplatform for Vaccination Immunotherapy of Cancer
Lei Zhou et al.
NANO LETTERS (2020)
Co-delivery of Peptide Neoantigens and Stimulator of Interferon Genes Agonists Enhances Response to Cancer Vaccines
Daniel Shae et al.
ACS NANO (2020)
Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets
Cheng Xu et al.
ACS NANO (2020)
Protamine sulphate coated poly (lactide-co-glycolide) nanoparticles of MUC-1 peptide improved cellular uptake and cytokine release in mouse antigen presenting cells
Kiran Jyoti et al.
JOURNAL OF MICROENCAPSULATION (2020)
Proton-driven transformable nanovaccine for cancer immunotherapy
Ningqiang Gong et al.
NATURE NANOTECHNOLOGY (2020)
Adaptable antigen matrix platforms for peptide vaccination strategies and T cell-mediated anti-tumor immunity
Sjoerd T. T. Schetters et al.
BIOMATERIALS (2020)
Exosome-based immunotherapy: a promising approach for cancer treatment
Zhijie Xu et al.
MOLECULAR CANCER (2020)
Rod-Scale Design Strategies for Immune-Targeted Delivery System toward Cancer Immunotherapy
Xiupeng Wang et al.
ACS NANO (2019)
Positron Emission Tomography-Guided Photodynamic Therapy with Biodegradable Mesoporous Silica Nanoparticles for Personalized Cancer Immunotherapy
Cheng Xu et al.
ACS NANO (2019)
Development of an In Situ Cancer Vaccine via Combinational Radiation and Bacterial-Membrane-Coated Nanoparticles
Ravi B. Patel et al.
ADVANCED MATERIALS (2019)
A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy
Hathaichanok Phuengkham et al.
ADVANCED MATERIALS (2019)
Neoantigen vaccine: an emerging tumor immunotherapy
Miao Peng et al.
MOLECULAR CANCER (2019)
Best practices for bioinformatic characterization of neoantigens for clinical utility
Megan M. Richters et al.
GENOME MEDICINE (2019)
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients
Michal Bassani-Sternberg et al.
FRONTIERS IN IMMUNOLOGY (2019)
Engineering patient-specific cancer immunotherapies
Lindsay Scheetz et al.
NATURE BIOMEDICAL ENGINEERING (2019)
A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma
Apostolos Sarivalasis et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy
Xiao Han et al.
SCIENCE ADVANCES (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
Qian Chen et al.
NATURE NANOTECHNOLOGY (2019)
Preparation and Characterization of Syringic Acid-Loaded TPGS Liposome with Enhanced Oral Bioavailability and In Vivo Antioxidant Efficiency
Yingkun Liu et al.
AAPS PHARMSCITECH (2019)
Alternative tumour-specific antigens
Christof C. Smith et al.
NATURE REVIEWS CANCER (2019)
Designable Immune Therapeutical Vaccine System Based on DNA Supramolecular Hydrogels
Yu Shao et al.
ACS APPLIED MATERIALS & INTERFACES (2018)
Nanomedicine for tumor microenvironment modulation and cancer treatment enhancement
Jingjing Liu et al.
NANO TODAY (2018)
A facile approach to enhance antigen response for personalized cancer vaccination
Aileen Weiwei Li et al.
NATURE MATERIALS (2018)
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
P. M. Forde et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Designer vaccine nanodiscs for personalized cancer immunotherapy
Rui Kuai et al.
NATURE MATERIALS (2017)
The Five Immune Forces Impacting DNA-Based Cancer Immunotherapeutic Strategy
Suneetha Amara et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
A STING-activating nanovaccine for cancer immunotherapy
Min Luo et al.
NATURE NANOTECHNOLOGY (2017)
Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
Yuanzeng Min et al.
NATURE NANOTECHNOLOGY (2017)
Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
Guizhi Zhu et al.
NATURE COMMUNICATIONS (2017)
Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy
Hidemitsu Kitamura et al.
CANCER SCIENCE (2017)
Efficient Nanovaccine Delivery in Cancer Immunotherapy
Guizhi Zhu et al.
ACS NANO (2017)
Polyethylenimine-coated SPIONs trigger macrophage activation through TLR-4 signaling and ROS production and modulate podosome dynamics
Vladimir Mulens-Arias et al.
BIOMATERIALS (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
Nanoparticle Drug Delivery Systems Designed to Improve Cancer Vaccines and Immunotherapy
Yuchen Fan et al.
VACCINES (2015)
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
Susan N. Thomas et al.
BIOMATERIALS (2014)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
A vaccine targeting mutant IDH1 induces antitumour immunity
Theresa Schumacher et al.
NATURE (2014)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
Hirokazu Matsushita et al.
NATURE (2012)
Expression of tumour-specific antigens underlies cancer immunoediting
Michel DuPage et al.
NATURE (2012)
Stat3 Inhibition Activates Tumor Macrophages and Abrogates Glioma Growth in Mice
Leying Zhang et al.
GLIA (2009)
Infection-mimicking materials to program dendritic cells in situ
Omar A. Ali et al.
NATURE MATERIALS (2009)
Induction of tumor-specific CD4+ and CD8+ T-Cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine
Marij J. P. Welters et al.
CLINICAL CANCER RESEARCH (2008)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
The path forward for biofuels and biomaterials
AJ Ragauskas et al.
SCIENCE (2006)
Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA
S Koido et al.
JOURNAL OF IMMUNOLOGY (2000)